Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Johnson & Johnson

    NYSE: JNJ · Real-Time Price · USD
    154.89
    -2.21 (-1.41%)
    At close: Jun 16, 2025, 1:44 PM
    -1.41%
    Bid 154.88
    Market Cap 372.68B
    Revenue (ttm) 89.33B
    Net Income (ttm) 21.81B
    EPS (ttm) 8.99
    PE Ratio (ttm) 17.23
    Forward PE 14.1
    Analyst Hold
    Ask 154.9
    Volume 3,427,310
    Avg. Volume (20D) 9,009,315
    Open 156.42
    Previous Close 157.10
    Day's Range 154.61 - 156.50
    52-Week Range 140.68 - 169.99
    Beta 0.41

    About JNJ

    undefined

    [Read more]
    Industry n/a
    Sector n/a
    IPO Date n/a
    Employees NaN
    Stock Exchange n/a
    Ticker Symbol JNJ
    Website n/a
    Full Company Profile

    Analyst Forecast

    According to 0 analyst ratings, the average rating for JNJ stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.

    Stock Forecasts

    Why Price Moved

    Why Price Moved is a one-sentence explanation of why a stock is moving higher or down. By removing noise and collecting signals from news, press releases and SEC filings, we can pinpoint the trigger for price movements.
    1 month ago
    -3.7%
    Johnson & Johnson shares are trading lower after L... Unlock content with Pro Subscription
    2 months ago
    -7.59%
    Johnson & Johnson shares are trading lower after a Federal Judge rejected the company's subsidiary Red River Talc's request to approve its prepackaged bankruptcy plan.
    news image

    Just now · zacks.com

    Can J&J's Innovative Medicines Unit Sustain Growth Amid Stelara LOE?

    JNJ's Innovative Medicines unit shows a growth trend, defying Stelara LOE and the negative impact of the Part D redesign.

    1 day ago · youtube.com

    Johnson & Johnson CEO: 'We're in the Golden Era of Medical Innovation'

    Johnson & Johnson Chairman and CEO Joaquin Duato believes that we are now in a “golden era” of innovation, particularly in the United States. Venture capital plays a vital early-stage role, but big ph...

    news image

    5 days ago · seekingalpha.com

    Johnson & Johnson (JNJ) Presents at Goldman Sachs 46th Annual Global Healthcare Conference Transcript

    Johnson & Johnson (NYSE:JNJ ) Goldman Sachs 46th Annual Global Healthcare Conference Call June 11, 2025 3:20 PM ET Company Participants Tom Cavanaugh - Company Group Chairman for North America Innovat...

    news image

    4 days ago · zacks.com

    Why Johnson & Johnson (JNJ) is a Top Momentum Stock for the Long-Term

    Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

    news image

    4 days ago · zacks.com

    JNJ vs. MRK: Which Healthcare Titan Offers Better Growth Prospects?

    JNJ edges ahead of MRK with stronger 2025 growth prospects, a broader pipeline and better sales momentum despite key headwinds.

    news image

    5 days ago · fool.com

    5 Unstoppable Dividend Stocks to Buy If There's a Stock Market Sell-Off

    Volatility is a part of life for long-term investors. The reasons the market goes up or down change, but the constant is that high-quality stocks, businesses that increasingly make more money over tim...

    news image

    6 days ago · businesswire.com

    Johnson & Johnson Elects Daniel Pinto, President, JPMorganChase to its Board of Directors

    NEW BRUNSWICK, N.J.--(BUSINESS WIRE)--Johnson & Johnson (NYSE: JNJ) announced today that Daniel Pinto, President, JPMorganChase, has been elected to its Board of Directors. “We are thrilled to have Da...

    news image

    1 week ago · marketbeat.com

    3 Top Dividend Stocks Analysts Are Bullish on Right Now

    We're at the end of earnings season. That means it's time for analysts to weigh in on the outlook for specific stocks.

    news image

    1 week ago · https://247wallst.com

    Make an Easy $2,852 in Passive Income By Invest $25,000 in These Dividend Stocks Today

    Key Points Put your money to work. Make it make you money. It can make you a good deal of consistent money if you invest wisely in higher-yielding Dividend King stocks. Are you ahead, or behind on ret...

    news image

    1 week ago · zacks.com

    Johnson & Johnson (JNJ) Is a Trending Stock: Facts to Know Before Betting on It

    Johnson & Johnson (JNJ) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.

    Add to Watchlist